Back to Search
WALTER QUAN, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1760479000IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
35056028(OH)74451(CA)
Education
OHIO STATE UNIVERSITY COLLEGE OF MEDICINE
Class of 1986
Research & Publications (20)
High-dose intensity pulse interleukin-2 with famotidine in metastatic kidney cancer.
PMID 19409039·Cancer Biother Radiopharm·2009
3-trial
Activity of continuous infusion + pulse interleukin-2 with famotidine in metastatic melanoma.
PMID 19243244·Cancer Biother Radiopharm·2009
3-trial
High-dose intensity pulse interleukin-2 with famotidine has activity in metastatic melanoma.
PMID 18999936·Cancer Biother Radiopharm·2008
8-other
Re-estimation of internal dose from natural radionuclides for Chinese adult men.
PMID 18346964·Radiat Prot Dosimetry·2008
8-other
Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer.
PMID 18298334·Cancer Biother Radiopharm·2008
8-other
Diagnostic value of magnetocardiography in patients with coronary heart disease and in-stent restenosis.
PMID 18208660·Chin Med J (Engl)·2008
8-other
[Purification function and ecological services value of Crassostrea sp. in Yangtze River estuary].
PMID 17615887·Ying Yong Sheng Tai Xue Bao·2007
7-preclinical
Uptake and distribution of N, P and heavy metals in three dominant salt marsh macrophytes from Yangtze River estuary, China.
PMID 17306362·Mar Environ Res·2007
8-other
Continuous infusion interleukin-2 and intravenous famotidine in metastatic melanoma.
PMID 17257076·Cancer Biother Radiopharm·2006
3-trial
Continuous infusion interleukin-2 and famotidine in metastatic kidney cancer.
PMID 17105423·Cancer Biother Radiopharm·2006
3-trial
Activity of continuous infusion plus pulse interleukin-2 with famotidine in patients with metastatic kidney cancer or melanoma previously treated with interleukin-2.
PMID 17105418·Cancer Biother Radiopharm·2006
8-other
[Magnetocardiography changes in coronary artery disease patients with normal or unspecialized resting electrocardiogram].
PMID 16842664·Zhonghua Xin Xue Guan Bing Za Zhi·2006
2-rct
[Evaluation of cerebral vasospasm resulting from subarachnoid hemorrhage with 1H-magnetic resonance spectroscopy].
PMID 16546746·Nan Fang Yi Ke Da Xue Xue Bao·2006
7-preclinical
Correlation between development of pulmonary edema and response of pulmonary metastases of metastatic melanoma and kidney cancer to high-dose continuous-infusion interleukin-2.
PMID 15869448·Cancer Biother Radiopharm·2005
8-other
High-dose continuous infusion plus pulse interleukin-2 and famotidine in metastatic kidney cancer.
PMID 15778577·Cancer Biother Radiopharm·2005
8-other
Administration of high-dose continuous infusion interleukin-2 to patients age 70 or over.
PMID 15778574·Cancer Biother Radiopharm·2005
3-trial
High-dose continuous infusion plus pulse interleukin-2 and famotidine in melanoma.
PMID 15665626·Cancer Biother Radiopharm·2004
8-other
Repeated cycles with 72-hour continuous infusion interleukin-2 in kidney cancer and melanoma.
PMID 15285881·Cancer Biother Radiopharm·2004
3-trial
[Advances in research of biological purification of eutrophic water body].
PMID 14997677·Ying Yong Sheng Tai Xue Bao·2003
6-review
Bolus followed by continuous infusion interleukin-2 in patients with metastatic malignant melanoma and kidney cancer previously treated with interleukin-2.
PMID 14503947·Cancer Biother Radiopharm·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 26520 CACTUS AVE
MORENO VALLEY, CA 92555 - Phone
- (909) 558-4910
Quick Facts
- NPI
- 1760479000
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 40
- Publications
- 20
Are you this provider?
Claim Your Profile